Total homocysteine in pediatric patients.

Determination of plasma total homocysteine (tHcy; the sum of all forms of thiol derivatives that form homocysteine by reduction) (1) is essential for diagnosis and follow-up of homocystinuric patients (2) and for detection of moderate hyperhomocysteinemia, a risk factor for coronary, cerebral, and peripheral vascular disease (3). In childhood, moderate hyperhomocysteinemia may result from several genetic, nutritional (4), and iatrogenic factors (1), renal failure (5), HIV (6), and cancer (1). Plasma tHcy in children may be a useful biochemical marker for a genetic risk of premature atherosclerosis (1). Various methods to measure tHcy have been described during the last decade, but HPLC with fluorescence detection is the most common (4)(7). Age- and sex-specific reference intervals for adults have been reported (4), considering even vitamin status (8), but data for children are sparse and inconsistent [ 9 , 10] , and no evidence is available in Mediterranean countries, where dietary vitamin content differs from that in Northern Europe or North America. Our goal was to establish reference values for a pediatric population in our geographical area with our working conditions so that we could compare the values in further studies with those of children at risk for moderate hyperhomocysteinemia. Specimens were collected from …

[1]  M. Tsai Laboratory assessment of mild hyperhomocysteinemia as an independent risk factor for occlusive vascular diseases. , 1996, Clinical chemistry.

[2]  K. Rasmussen,et al.  Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. , 1996, Clinical chemistry.

[3]  P. Ueland,et al.  Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection. , 1996, The American journal of clinical nutrition.

[4]  S. Vollset,et al.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.

[5]  R. L. Hagan Determination of Plasma Homocysteine by HPLC with Fluorescence Detection: A Survey of Current Methods , 1993 .

[6]  P. Ueland,et al.  Total homocysteine in plasma or serum: methods and clinical applications. , 1993, Clinical chemistry.

[7]  W. Vermaak,et al.  Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. , 1993, The American journal of clinical nutrition.

[8]  T. Bottiglieri,et al.  Measurement of total plasma and cerebrospinal fluid homocysteine by fluorescence following high-performance liquid chromatography and precolumn derivatization with o-phthaldialdehyde. , 1992, Journal of chromatography.

[9]  J. Ordovás,et al.  Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  B. Vester,et al.  High Performance Liquid Chromatography Method for Rapid and Accurate Determination of Homocysteine in Plasma and Serum , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[11]  P. Kamoun,et al.  Concentrations of total homocysteine in plasma in chronic renal failure. , 1990, Clinical chemistry.

[12]  P. Ueland,et al.  Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. , 1989, The Journal of laboratory and clinical medicine.

[13]  K.,et al.  Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. , 1986, The Journal of clinical investigation.